1 IN. DI LETTURA
Dec 20 (Reuters) - BioSphere Medical Inc BSMD.O said it agreed to collaborate with DuPont's (DD.N) unit, DuPont Applied BioSciences, to evaluate potential peripheral vascular and embolotherapy research, development, and manufacturing engineering projects.
Under the agreement, BioSphere has agreed to make payments to DuPont of up to $500,000 based upon the achievement of specified milestones, the company said in a statement. (Reporting by Dhanya Skariachan in Bangalore; )